How Ought the Law to Deal with Implanted Medical Devices – Professor Muireann Quigley, University of Birmingham

Feb 12, 2021 | engineering and tech, health and medicine

About this episode

Attached and implanted technologies are now part of everyday life for many millions of people. Yet as the capabilities of these devices have advanced rapidly in recent years, lawmakers have struggled to keep pace. Professor Muireann Quigley at the University of Birmingham believes that it is now more critical than ever that the law catches up with the technological and social change wrought by attached and implanted medical devices, especially ‘smart’ ones. Through the Everyday Cyborgs 2.0 and DIY Diabetes projects, she and her colleagues hope to bring law, regulation, and policy regarding these technologies into the 21st century.

 

 

 

This work is licensed under a Creative Commons Attribution 4.0 International LicenseCreative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

Related episodes

Prof. Christian Bréchot | ALF5755: A New Therapeutic Avenue for Alzheimer’s and Diabetic Neuropathy

Prof. Christian Bréchot | ALF5755: A New Therapeutic Avenue for Alzheimer’s and Diabetic Neuropathy

Many diseases become more likely to emerge as we age, with metabolic disorders such as diabetes, and neurodegenerative conditions, such as Alzheimer’s disease, representing two frequent manifestations of poor health in old age. While many age-related diseases present very differently, many share common underlying mechanisms. These include inflammation, a build-up of reactive oxygen molecules that can damage cellular components, and a lack of sensitivity to insulin. Treatments that can effectively target these mechanisms could have transformational effects on the age-related diseases that are fueled by them, including potentially preventing such diseases from developing in the first place. Prof. Christian Bréchot and colleagues at The Healthy Aging Company have developed a drug candidate: ALF5755, the pharmacological name of a protein called Hepatocarcinoma-Intestine-Pancreas, or HIP for short, also named Reg3A, that has shown exciting evidence of effectiveness on the cognitive disorders which occur during Alzheimer’s disease and the peripheral nerve damage that often occurs in diabetes, which is called diabetic neuropathy.

Dr Christopher Buck | Mint: A Fresh Perspective in the Fight Against Covid

Dr Christopher Buck | Mint: A Fresh Perspective in the Fight Against Covid

Dr. Christopher Buck, a virologist at the US National Cancer Institute in Bethesda, Maryland, has been working to spread the word about a growing body of scientific literature suggesting that mint and related herbs can help fight Covid infections. In his recent review article, “The Mint Versus Covid Hypothesis,” he makes a case for the idea that decentralized clinical trials could be used to more thoroughly explore this exciting idea.

Professor Steven Brams | A Game That Stymies AI

Professor Steven Brams | A Game That Stymies AI

AI appears all-powerful when playing sophisticated games such as Chess and Go against human opponents. Moreover, recent developments in AI have allowed it to summarize bodies of complex text, generate images and even video. These developments come with warnings that AI could replace many jobs, undermine democratic elections or even pose a threat to the existence of humanity. However, AI is largely based on observing and learning patterns; so, what happens when there are no patterns? Professor Steven Brams of New York University and colleagues have analyzed the potential of beating AI when playing a deceptively simple game called Catch-Up, simply by making random moves.

Dr Katty Kang | Deciphering the Molecular Origins of Brain Disorders

Dr Katty Kang | Deciphering the Molecular Origins of Brain Disorders

During brain development, anomalies may arise which lead to serious conditions such as epilepsy, triggering seizures and requiring lifelong monitoring and medication. However, the underlying causes and the way in which these defects occur are not completely understood. Dr Katty (Jing-Qiong) Kang and colleagues at Vanderbilt University Medical Centre in the USA have conducted extensive research into the molecular mechanisms associated with developmental brain disorders, with a focus on genetic epilepsy. They propose novel therapeutic targets to effectively manage symptoms and improve clinical outcomes by targeting the root cause.

Increase the impact of your research

• Good science communication helps people make informed decisions and motivates them to take appropriate and affirmative action.
• Good science communication encourages everyday people to be scientifically literate so that they can analyse the integrity and legitimacy of information.
• Good science communication encourages people into STEM-related fields of study and employment.
• Good public science communication fosters a community around research that includes both members of the public, policymakers and scientists.
• In a recent survey, 75% of people suggested they would prefer to listen to an interesting story than read it.

Step 1 Upload your science paper

Step 2 SciPod script written

Step 3 Voice audio recorded

Step 4 SciPod published